Farzaneh Ashrafi
Overview
Explore the profile of Farzaneh Ashrafi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rayati M, Mohammadifard N, Vafaei Z, Shekarchizadeh M, Mostafavi S, Zavar R, et al.
ARYA Atheroscler
. 2024 Dec;
20(4):1-6.
PMID: 39717426
Due to the shared risk factors between cardiovascular disease (CVD) and certain cancers such as breast cancer (BC) and colorectal cancer (CRC), our study aimed to assess the CVD risk...
2.
Ghaedrahmati F, Esmaeil N, Akbari V, Ashrafi F
Heliyon
. 2024 Aug;
10(15):e35509.
PMID: 39170467
Adoptive immunotherapies that use functional NK cells depend on the availability of sufficient numbers of these cells. We expanded umbilical cord blood (UCB)-CD34 HSCs for 2 weeks and then differentiated...
3.
Sadeghi A, Gardashti R, Ashrafi F, Mehrzad V
Int J Hematol Oncol Stem Cell Res
. 2024 Apr;
18(1):47-52.
PMID: 38680719
Recurrence of ALL in the central nervous system, CNS Relapse, is known as a poor prognostic factor. Few studies have been performed on the CNS Relapse in adults with ALL....
4.
Hasanpour Z, Choopani S, Ashrafi F, Talebi A, Nematbaksh M
Adv Biomed Res
. 2024 Mar;
13:14.
PMID: 38525397
Background: High-dose methotrexate (HDMTX) as a cytotoxic agent might cause various side effects. Hyperhydration has been implemented as the major strategy to decrease the potential risk of toxicities induced by...
5.
Malakoutikhah Z, Ashrafi F, Derakhshandeh A
Adv Hematol
. 2023 Nov;
2023:5593635.
PMID: 38029004
Aim: The Hyper-CVAD regimen has shown promising results for adult patients with acute lymphoblastic leukemia (ALL), as designed by the MD Anderson Cancer Center (MDACC). This treatment has resulted in...
6.
Ashrafi F, Sadeghi A, Derakhshandeh A, Oghab P
J Res Med Sci
. 2023 May;
28:30.
PMID: 37213449
Background: Asparaginase-based treatment regimen for acute lymphocytic leukemia (ALL) is considered as feasible, but there is still a lack of data. In this study, considering the results of other regimen...
7.
Darakhshandeh A, Fathi E, Gholami A, Ashrafi F, Mehrzad V, Nasri E
Int J Biochem Mol Biol
. 2023 Mar;
14(1):10-16.
PMID: 36936611
Background: Bloodstream infections are serious complications in neutropenic cancer patients. There has been a universal pickup in multidrug resistant (MDR) strains. For individuals who are at high risk for infections...
8.
Amra B, Ashrafi F, Torki M, Hashemi M, Shirzadi M, Soltaninejad F, et al.
Adv Biomed Res
. 2023 Mar;
12:14.
PMID: 36926422
Background: Coronavirus disease 2019 has become a public health concern with a high number of fatalities. Thalidomide can target inflammatory mediators and decrease inflammation in SARS-CoV-2. Materials And Methods: An...
9.
Eshghi P, Abolghasemi H, Akhlaghi A, Ashrafi F, Bordbar M, Hajifathali A, et al.
Clin Appl Thromb Hemost
. 2023 Jan;
29:10760296221130335.
PMID: 36630731
Data describing physicians' and patients' perspectives towards immune thrombocytopenia (ITP) management and impact of disease in Iran are limited. This ITP World Impact Survey was conducted between October 2019 and...
10.
Shokrollahi S, Ashrafi F, Iraj B, Omid A, Mansouri V
J Educ Health Promot
. 2022 Dec;
11:322.
PMID: 36568003
Background: Role of multimedia training materials on Mini-CEX scores of internal medicine residents. We aimed to assess the effect of multi multimedia training materials on Mini-CEX scores of internal medicine...